Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists
- 16 May 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (11) , 5391-5402
Abstract
In our search for new cannabinoid receptor modulators, we describe herein the design and synthesis of three sets of indole-based ligands characterized by an acetamide, oxalylamide, or carboxamide chain, respectively. Most of the compounds showed affinity for CB2 receptors in the nanomolar range, with Ki values spanning 3 orders of magnitude (377–0.37 nM), and moderate to good selectivity over CB1 receptors. Their in vitro functional activity as inverse agonists was confirmed in vivo in the formalin test of acute peripheral and inflammatory pain in mice, in which compounds 10a and 11e proved to be able to reverse the effect of the CB2 selective agonist COR167.Keywords
This publication has 69 references indexed in Scilit:
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- CB2 cannabinoid receptor targets mitogenic Gi protein–cyclin D1 axis in osteoblastsJournal of Bone and Mineral Research, 2010
- Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDSJournal of Neuroimmune Pharmacology, 2010
- Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathyFree Radical Biology and Medicine, 2010
- Endocannabinoids and immune regulation☆Pharmacological Research, 2009
- WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s diseaseEuropean Journal of Neuroscience, 2009
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMicrovascular Research, 2009
- Cannabinoid CB2 receptors in human brain inflammationBritish Journal of Pharmacology, 2008
- Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injuryThe FASEB Journal, 2007
- The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetJournal of Neurochemistry, 2007